Title: Impact of ‘‘Advance Patients Care Plan’’ in Cardiovascular Disorders
Authors: Dr Soumadip Das, Dr Rajat Rana, Dr Aravinda Swami, Dr C K Dhanapal, Dr K.K. Perumal
DOI: http://dx.doi.org/10.18535/jmscr/v4i7.16
Background and Objective: Cardiovascular deaths and disorders have increased at a fast rate in low and middle-income countries. In India most of population pays their healthcare bills out of their own pocket, so there is always a need to reduce the economic burden on the patients. The research was conducted to implement and analyze “Advance Patients Care Plan” for cardiovascular disorders and its impact in terms of patient therapeutic outcomes. Methods: In this single blinded double arm interventional research three different strategic interventions were implemented under “Advance Patients Care Plan” namely Cost minimization by prescribing cheap brands/generics, Early ADR detection & prevention and Life style modifications. The outcomes were recorded in terms of patient’s therapeutic outcomes, quality of life and reduction in economic burden. The data was analyzed statistically. Results: The overall mean score of WHO QoL BREF questionnaire of experimental group was 58.2±8.65 which was comparatively higher than 45.95±1.08 of control group. The overall mean MLHFQ score was 38.33±6.98 and 65.67±3.75 for experimental group and control group respectively. The total cumulative therapy cost was accounted ₹ 240660 in Experimental Group whereas patients in Control Group spend ₹ 319114.80 on therapy. The Implemented ‘‘Advance Patients Care Plan’’ reduced total cost for therapy by ₹ 2615.16 for each patient. Interpretation and Conclusions: Advance Patients Care Plan in addition to treatment showed significant evidence in improvement of patients’ therapeutic outcomes, improved quality of life and reduced economic burden on the patients. Key words: Pharmacoeconomics, Advance Patients Care Plan, Therapeutic outcome, Quality of Life, Therapy, cost
Abstract
